Abstract
Surgery is considered the treatment of choice for patients with resectable stage I and II (and some patients with stage IIIA)non-small cell lung cancer (NSCLC), but there have been no previously
published systematic reviews. METHODS: A systematic review and meta-analysis of randomised controlled trials was conducted to determine whether surgical resection improves disease specific mortality in patients with stages I-IIIA NSCLC compared with non-surgical treatment, and to
compare the efficacy of different surgical approaches. RESULTS: Eleven trials were included. No studies had untreated control groups.
| Original language | English |
|---|---|
| Pages (from-to) | 597 - 603 |
| Number of pages | 7 |
| Journal | Thorax |
| Volume | 61 |
| Issue number | 7 |
| Publication status | Published - 2006 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver